Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD
Clinical trial NCT02884908 · COMPLETED
Trial details
- NCT number
- NCT02884908
- Sponsor
- University of Maryland, Baltimore
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-07
- Primary completion
- 2022-01-19
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.